Woodline Partners’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-292,437
Closed -$1.12M 1115
2026
Q1
$1.12M Sell
292,437
-1,033,418
-78% -$4.24M ﹤0.01% 874
2025
Q4
$4.92M Hold
1,325,855
0.02% 627
2025
Q3
$18.7M Buy
1,325,855
+71
+0% +$1.11K 0.09% 300
2025
Q2
$25.5M Hold
1,325,784
0.13% 227
2025
Q1
$14.7M Buy
+1,325,784
New +$15.8M 0.1% 287
2023
Q1
Sell
-13,262
Closed -$5.14M 740
2022
Q4
$5.14M Sell
13,262
-3,235
-20% -$912K 0.07% 312
2022
Q3
$3.94M Buy
16,497
+273
+2% +$73.1K 0.06% 341
2022
Q2
$3.62M Sell
16,224
-4,429
-21% -$1.91M 0.06% 306
2022
Q1
$14.1M Buy
20,653
+5,253
+34% +$3.16M 0.23% 132
2021
Q4
$10.6M Buy
15,400
+1,521
+11% +$1.12M 0.15% 186
2021
Q3
$10.3M Buy
13,879
+1,650
+13% +$1.12M 0.17% 160
2021
Q2
$9.17M Buy
12,229
+2,594
+27% +$1.98M 0.17% 145
2021
Q1
$7.86M Sell
9,635
-6
-0.1% -$4.63K 0.17% 149
2020
Q4
$8.22M Buy
9,641
+1,269
+15% +$978K 0.22% 129
2020
Q3
$6.28M Buy
+8,372
New +$6.88M 0.21% 112

Other funds holding OM

Woodline Partners's OM Position: Q2 2026 in Review

Woodline Partners sold out of Outset Medical (OM) in Q2 2026, closing a stake of 292,437 shares — an estimated $1.12M sold.

Woodline Partners first reported a position in OM in Q3 2020 and held it in 15 quarters. The position peaked at $25.5M in Q2 2025. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Woodline Partners reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
  • Woodline Partners sold 292,437 Outset Medical shares in Q2 2026, an estimated $1.12M.
  • Woodline Partners first reported a position in Outset Medical in Q3 2020 and held it in 15 quarters.
  • Woodline Partners's Outset Medical position peaked at $25.5M in Q2 2025.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.